Carlyle completed the acquisition of a majority stake in Tarrytown Expocare Pharmacy from Sheridan Capital Partners.

Carlyle, a global investment firm, completed the acquisition of a majority stake in Tarrytown Expocare Pharmacy, a pharmacy focused exclusively on serving the intellectual and developmental disability and behavioral health communities, from Sheridan Capital Partners, a private equity firm. Financial terms were not disclosed. “We believe Tarrytown’s specialized IDD pharmacy model provides exceptional support to caregivers in improving their quality of care for IDD patients. We look forward to backing the Tarrytown team as it invests in enhancing and expanding the Company’s high-touch offering to continue serving IDD patients," Joe Bress, Carlyle Partner and Global Co-Head of Healthcare.